ERO1B
Basic information
Region (hg38): 1:236214681-236282019
Previous symbols: [ "ERO1LB" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ERO1B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 31 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 31 | 2 | 1 |
Variants in ERO1B
This is a list of pathogenic ClinVar variants found in the ERO1B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-236218524-T-C | Benign (Feb 26, 2018) | |||
1-236218543-A-T | not specified | Uncertain significance (Oct 16, 2023) | ||
1-236218563-T-C | not specified | Uncertain significance (Jan 26, 2022) | ||
1-236220862-T-C | not specified | Uncertain significance (May 13, 2022) | ||
1-236220928-G-T | not specified | Uncertain significance (May 09, 2024) | ||
1-236220932-A-G | not specified | Uncertain significance (Mar 28, 2023) | ||
1-236220943-A-T | not specified | Uncertain significance (Jul 09, 2021) | ||
1-236225098-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
1-236226296-A-C | not specified | Uncertain significance (Jun 22, 2023) | ||
1-236226306-T-C | not specified | Uncertain significance (Jan 19, 2022) | ||
1-236226311-G-A | not specified | Uncertain significance (Mar 04, 2024) | ||
1-236226333-T-C | not specified | Uncertain significance (Mar 14, 2023) | ||
1-236226348-T-C | not specified | Uncertain significance (May 09, 2022) | ||
1-236226392-T-G | not specified | Uncertain significance (Mar 20, 2024) | ||
1-236226464-C-T | not specified | Uncertain significance (Sep 26, 2022) | ||
1-236226472-G-C | not specified | Uncertain significance (May 27, 2022) | ||
1-236226697-C-T | not specified | Uncertain significance (Oct 27, 2023) | ||
1-236226704-T-C | not specified | Uncertain significance (Jun 05, 2023) | ||
1-236232837-C-T | not specified | Uncertain significance (Nov 17, 2023) | ||
1-236235800-G-A | Developmental cataract | Uncertain significance (Dec 01, 2020) | ||
1-236243445-C-T | not specified | Likely benign (Jun 06, 2023) | ||
1-236249901-T-C | not specified | Uncertain significance (Jul 05, 2023) | ||
1-236249912-T-G | not specified | Uncertain significance (Jan 26, 2023) | ||
1-236249948-T-C | not specified | Uncertain significance (Oct 13, 2023) | ||
1-236253432-G-C | not specified | Uncertain significance (Nov 08, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ERO1B | protein_coding | protein_coding | ENST00000354619 | 16 | 66465 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.76e-9 | 0.977 | 125681 | 0 | 66 | 125747 | 0.000262 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.911 | 198 | 238 | 0.834 | 0.0000123 | 3039 |
Missense in Polyphen | 78 | 106.62 | 0.73156 | 1323 | ||
Synonymous | -0.358 | 85 | 80.9 | 1.05 | 0.00000391 | 823 |
Loss of Function | 2.22 | 19 | 32.7 | 0.581 | 0.00000185 | 396 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000330 | 0.000330 |
Ashkenazi Jewish | 0.000398 | 0.000397 |
East Asian | 0.000507 | 0.000489 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000250 | 0.000246 |
Middle Eastern | 0.000507 | 0.000489 |
South Asian | 0.000334 | 0.000327 |
Other | 0.000354 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Oxidoreductase involved in disulfide bond formation in the endoplasmic reticulum. Efficiently reoxidizes P4HB/PDI, the enzyme catalyzing protein disulfide formation, in order to allow P4HB to sustain additional rounds of disulfide formation. Other protein disulfide isomerase family members can also be reoxidized, but at lower rates compared to P4HB, including PDIA2 (50% of P4HB reoxidation rate), as well as PDIA3, PDIA4, PDIA6 and NXNDC12 (<10%). Following P4HB reoxidation, passes its electrons to molecular oxygen via FAD, leading to the production of reactive oxygen species (ROS) in the cell. May be involved in oxidative proinsulin folding in pancreatic cells, hence may play a role in glucose homeostasis. {ECO:0000269|PubMed:11707400, ECO:0000269|PubMed:21091435}.;
- Pathway
- Protein processing in endoplasmic reticulum - Homo sapiens (human);Peptide hormone metabolism;Metabolism of proteins;Insulin processing
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- 0.75
- rvis_percentile_EVS
- 86.65
Haploinsufficiency Scores
- pHI
- 0.157
- hipred
- N
- hipred_score
- 0.493
- ghis
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Ero1lb
- Phenotype
- homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- protein folding;4-hydroxyproline metabolic process;protein maturation by protein folding;insulin processing;extracellular matrix organization;protein folding in endoplasmic reticulum;glucose homeostasis;cell redox homeostasis;oxidation-reduction process
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane
- Molecular function
- protein disulfide isomerase activity;protein binding;protein disulfide oxidoreductase activity;oxidoreductase activity;oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor;unfolded protein binding